JNGLX
Price
$66.10
Change
-$0.15 (-0.23%)
Updated
Jul 2 closing price
Net Assets
4.35B
RYCFX
Price
$40.80
Change
+$0.66 (+1.64%)
Updated
Jul 2 closing price
Net Assets
83.39M
Interact to see
Advertisement

JNGLX vs RYCFX

Header iconJNGLX vs RYCFX Comparison
Open Charts JNGLX vs RYCFXBanner chart's image
Janus Henderson Global Life Sciences D
Price$66.10
Change-$0.15 (-0.23%)
VolumeN/A
Net Assets4.35B
Rydex Biotechnology C
Price$40.80
Change+$0.66 (+1.64%)
VolumeN/A
Net Assets83.39M
JNGLX vs RYCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. RYCFX commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a StrongBuy and RYCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.35B vs. RYCFX (83.4M). JNGLX pays higher dividends than RYCFX: JNGLX (0.36) vs RYCFX (0.00). JNGLX was incepted earlier than RYCFX: JNGLX (27 years) vs RYCFX (24 years). RYCFX (2.43) is less costly to investors than JNGLX (0.80). RYCFX is a more actively managed with annual turnover of: 51.00 vs. JNGLX (35.00). JNGLX (2500) and RYCFX (2500) have matching initial minimum investment requirements. JNGLX annual gain was more profitable for investors over the last year : -12.19 vs. RYCFX (-21.37). JNGLX return over 5 years is better than : 5.07 vs. RYCFX (-44.68).
JNGLXRYCFXJNGLX / RYCFX
Total Expense Ratio0.802.4033%
Annual Report Gross Expense Ratio0.802.4333%
Fund Existence27 years24 years-
Gain YTD-2.416-1.157209%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B83.4M5,216%
Annual Yield % from dividends0.360.00-
Returns for 1 year-12.19-21.3757%
Returns for 3 years9.48-14.12-67%
Returns for 5 years5.07-44.68-11%
Returns for 10 years10.99-53.60-21%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZNCF143.884.17
+2.98%
AstraZeneca Plc
UBAAF4.68N/A
N/A
Urbana Corp.
CADLF4.60N/A
N/A
CADELER AS
EUXTF172.15N/A
N/A
Euronext NV
SLVDF0.16N/A
-2.66%
Silver Dollar Resources Inc.